Browsing by Author Brown, Michael P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2014Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?Tracey, Elizabeth; Brown, Michael P.; Neuhaus, Susan; Roder, David; Shahnam, Adel; Sorich, Michael; School of Public Health: Public HealthCan cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?, Journal of Evaluation in Clinical Practice, vol.20, 1, 2014,pp 74-80
2012Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialKefford, Richard (Rick); Long, Georgina; Arkenau, Tobias; Brown, Michael P.; et al, various; Falchook, GErald; Hamid, Omid; Infante, Jeffrey; Kim, Kevin; Kurzrock, Razelle; Millward, Michael; O'Day, Steven; Pavlick, Anna C.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreDabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial, The Lancet, vol.379, 9829, 2012,pp 1893-1901
2014Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF-inhibitor Dabrafenib (GSK2118436)Kefford, Richard (Rick); Long, Georgina; Arkenau, Hendrik-Tobias; Brown, Michael P.; Chin, Melvin; et al, .; Falchook, Gerald; Hamid, Omid; Infante, Jeffrey; Kim, Kevin; Kurzrock, Razelle; Millward, Michael; Pavlick, Anna C.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreDose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF-inhibitor Dabrafenib (GSK2118436), Clinical Cancer Research, vol.20, 17, 2014,pp 4449-4458
2015A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaKefford, Richard (Rick); Agarwala, Sanjiv; Bhatia, S.; Brachmann, C.; Brown, Michael P.; Clawson, A.; Conry, Robert; Del Vecchio, M.; Elias, I.; Ernst, S.; Grob, Jean Jacques; Gutzmer, R.; Hauschild, A; Haydon, A.; Hersh, Evan M.; Homsi, J.; Karnoub, M; Kendra, K.; Li, M.; Loquai, C.; Rebscgler, M. F.; Robert, Caroline; Testori, Alessandro; Western Clinical School: Westmead Institute for Medical ResA randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma, Annals of Oncology, vol.26, 11, 2015,pp 2267-2274
2014The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutationLong, Georgina; Brown, Michael P.; Central Clinical School: The Sydney Cancer CentreThe use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation, Asia-Pacific Journal of Clinical Oncology, vol.10, S3, 2014,pp 1-15